ケトライドの世界市場レポート 2025年

ケトライドの市場規模は、今後数年間で安定した成長が見込まれます。2029年には40億4,000万米ドルに成長し、CAGRは4.8%となります。予測期間の成長は、ケトライドの研究開発活動への投資、感染症スクリーニングプログラムの増加、医療支出の増加、抗菌薬スチュワードシップに対する意識の高まりに起因しています。予測期間における主な動向としては、感染症の革新的治療、標的治療の開発、感染症の診断と治療の進歩、新しいケトライド製剤の開発などが挙げられます。

感染症の流行増加は、ケトライド市場の成長を促進すると予想されます。細菌、ウイルス、真菌、寄生虫などの病原体によって引き起こされる感染症は、人から人へと感染し、さまざまな健康合併症を引き起こします。結核（TB）は、ケトライドの強力な細胞内活性が評価されている感染症の一例であり、これは結核の治療に極めて重要です。例えば、2024年2月、GOV.UKは、イングランドにおける結核患者が2023年に10.7％増加し、2022年の4,380人から4,850人に増加したと報告しました。結核のような感染症が増加の一途をたどるなか、ケトライドをはじめとする効果的な治療法への需要が高まることが予想されます。

ヘルスケア産業の拡大がケトライド市場の成長を牽引すると予想されます。ヘルスケア産業には、患者の治療、予防、リハビリ、緩和ケアに焦点を当てたさまざまな分野が含まれます。ヘルスケア産業が成長するにつれ、ケトライドの安全性と有効性を評価するための研究、臨床試験、規制プロセスをサポートすることで、ケトライドの開発と流通に重要な役割を果たしています。さらに、ヘルスケア業界は、ケトライドが安全かつ効率的に患者に投与されることを保証しています。例えば、2023年5月、米国ヘルスケア協会は、米国内の病院数の増加を報告し、2022年の6,093から6,129に増加しました。このようなヘルスケア・インフラの成長は、ケトライドのような治療の継続的な開発と採用をサポートし、市場開拓の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ケトライド PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のケトライド市場：成長率分析
• 世界のケトライド市場の実績：規模と成長, 2019-2024
• 世界のケトライド市場の予測：規模と成長, 2024-2029, 2034F
• 世界ケトライド総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のケトライド市場薬の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• テリスロマイシン
• セスロマイシン
• ソリトロマイシン
• 世界のケトライド市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 気管支炎
• 肺炎
• 副鼻腔炎
• 扁桃炎または咽頭炎
• 世界のケトライド市場微生物による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肺炎球菌
• インフルエンザ菌
• モラクセラ・カタラーリス
• クラミドフィラ肺炎
• マイコプラズマ肺炎
• 世界のケトライド市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル

第7章 地域別・国別分析

• 世界のケトライド市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のケトライド市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ケトライド市場：競合情勢
• ケトライド市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott Laboratories
• GSK PLC
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma Inc.
• Daiichi Sankyo Company Limited
• Shionogi & Company Limited
• Dr. Reddys Laboratories Ltd.
• Taisho Pharmaceutical Co. Ltd.
• Glenmark Pharmaceuticals Ltd.
• Zhejiang Yongtai Technology Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ケトライド市場2029：新たな機会を提供する国
• ケトライド市場2029：新たな機会を提供するセグメント
• ケトライド市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Ketolides, a class of antibiotics within the macrolide group, are derived from erythromycin, a 14-membered macrolide. They are created by replacing the cladinose sugar with a keto-group and incorporating a cyclic carbamate group into the lactone ring structure. Ketolides exert their antibiotic effects by inhibiting protein synthesis, thus impeding the production of essential proteins vital for bacterial maintenance and survival.

The primary drugs falling under the ketolides category include telithromycin, cethromycin, and solithromycin. Telithromycin, a semi-synthetic antibiotic of the ketolide class, is deployed in the treatment of respiratory tract infections. These antibiotics find application in a range of conditions, including bronchitis, pneumonia, sinusitis, tonsillitis, and pharyngitis. They target various microorganisms such as Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae. Ketolides are distributed through diverse channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others.

The ketolides market research report is one of a series of new reports from The Business Research Company that provides ketolides market statistics, including ketolides industry global market size, regional shares, competitors with a ketolides market share, detailed ketolides market segments, market trends and opportunities and any further data you may need to thrive in the ketolides industry. This ketolides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ketolides market size has grown steadily in recent years. It will grow from $3.22 billion in 2024 to $3.35 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, growing consumption of antibiotics, demand for effective and convenient treatments for infectious diseases, government initiatives.

The ketolides market size is expected to see steady growth in the next few years. It will grow to $4.04 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to investments in research and development activities for ketolides, growing number of screening programs for infectious diseases, incremental healthcare spending growing awareness of antimicrobial stewardship. Major trends in the forecast period include innovative treatments for infectious diseases, development of targeted therapies, advancements in diagnosis and treatment of infectious diseases, development of new ketolide formulations.

The rising prevalence of infectious diseases is expected to drive the growth of the ketolides market. Infectious diseases, caused by pathogens such as bacteria, viruses, fungi, or parasites, can spread from person to person, leading to a variety of health complications. Tuberculosis (TB) is one example of an infectious disease for which ketolides are being evaluated due to their potent intracellular activity, which is crucial for treating TB. For instance, in February 2024, GOV.UK reported that cases of tuberculosis in England increased by 10.7% in 2023, rising from 4,380 in 2022 to 4,850. As infectious diseases like tuberculosis continue to rise, the demand for effective treatments, including ketolides, is expected to grow.

The expansion of the healthcare industry is expected to drive the growth of the ketolides market. The healthcare industry encompasses various sectors focused on curing, preventing, rehabilitating, and providing palliative care for patients. As the healthcare sector grows, it plays a critical role in the development and distribution of ketolides by supporting research, clinical trials, and regulatory processes to assess their safety and effectiveness. Additionally, the healthcare industry ensures that ketolides are administered securely and efficiently to patients. For example, in May 2023, the American Health Care Association reported an increase in the number of hospitals in the U.S., rising from 6,093 in 2022 to 6,129. This growth in healthcare infrastructure supports the ongoing development and adoption of treatments like ketolides, thereby fueling market expansion.

The leading companies within the ketolides market are strongly committed to pioneering innovative drugs and treatment approaches, with the aim of gaining a competitive edge and maintaining their market position. For instance, AliquantumRx Inc., a US-based biotechnical research company, which, in June 2023, celebrated the approval of a patent by the United States Patent and Trademark Office (USPTO), a key agency under the Department of Commerce. This patent, titled 'salts and polymorphs of cethromycin for the treatment of bacterial and protozoan disease,' pertains to cethromycin, a ketolide antibiotic that demonstrates effectiveness against various infectious diseases caused by both bacteria and protozoa. These conditions encompass malaria, babesiosis, toxoplasmosis, diarrhea, and more. Notably, this newly granted patent significantly expands the possibilities for the use of cethromycin, potentially lowering the barriers to its commercialization and facilitating its application in treating a broader range of diseases.

The ketolides market is witnessing growth, primarily attributed to the increasing prevalence of chronic sinusitis. Chronic sinusitis is characterized by persistent inflammation in the sinus cavities around the nasal passages. Ketolides, a class of antibiotics with immunomodulatory and anti-inflammatory properties, find application in the treatment of various medical conditions. Given that chronic sinusitis involves inflammation of the sinuses, ketolides play a role in mitigating this inflammation and alleviating associated symptoms. For example, data from the US-based Centers for Disease Control and Prevention (CDC) as of January 2022 indicated that approximately 11.6% of adults in the United States had received diagnoses of sinusitis. Consequently, the expanding occurrence of chronic sinusitis serves as a driving force behind the growth of the ketolides market.

Major companies operating in the ketolides market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Shionogi & Company Limited, Dr. Reddys Laboratories Ltd., Taisho Pharmaceutical Co. Ltd., Glenmark Pharmaceuticals Ltd., Zhejiang Yongtai Technology Co. Ltd., Corden Pharma GmbH, Optimer Pharmaceuticals Inc., Vivimed Labs Limited, Wockhardt Ltd., Advanced Life Sciences Holdings Inc.

North America was the largest region in the ketolides market in 2024. The regions covered in ketolides report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ketolides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ketolides market consists of sales of solithera and ketek, arylalkyl and macrolactone rings. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ketolides Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ketolides market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ketolides ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ketolides market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Telithromycin; Cethromycin; Solithromycin
• 2) By Indication: Bronchitis; Pneumonia; Sinusitis; Tonsillitis Or Pharyngitis
• 3) By Microorganism: Streptococcus Pneumoniae; Haemophilus Influenzae; Moraxella Catarrhalis; Chlamydophila Pneumoniae; Mycoplasma Pneumoniae
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ketolides Market Characteristics

3. Ketolides Market Trends And Strategies

4. Ketolides Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Ketolides Growth Analysis And Strategic Analysis Framework

• 5.1. Global Ketolides PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Ketolides Market Growth Rate Analysis
• 5.4. Global Ketolides Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Ketolides Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Ketolides Total Addressable Market (TAM)

6. Ketolides Market Segmentation

• 6.1. Global Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Telithromycin
• Cethromycin
• Solithromycin
• 6.2. Global Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bronchitis
• Pneumonia
• Sinusitis
• Tonsillitis Or Pharyngitis
• 6.3. Global Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Streptococcus Pneumoniae
• Haemophilus Influenzae
• Moraxella Catarrhalis
• Chlamydophila Pneumoniae
• Mycoplasma Pneumoniae
• 6.4. Global Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels

7. Ketolides Market Regional And Country Analysis

• 7.1. Global Ketolides Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Ketolides Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ketolides Market

• 8.1. Asia-Pacific Ketolides Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ketolides Market

• 9.1. China Ketolides Market Overview
• 9.2. China Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ketolides Market

• 10.1. India Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ketolides Market

• 11.1. Japan Ketolides Market Overview
• 11.2. Japan Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ketolides Market

• 12.1. Australia Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ketolides Market

• 13.1. Indonesia Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ketolides Market

• 14.1. South Korea Ketolides Market Overview
• 14.2. South Korea Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ketolides Market

• 15.1. Western Europe Ketolides Market Overview
• 15.2. Western Europe Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ketolides Market

• 16.1. UK Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ketolides Market

• 17.1. Germany Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ketolides Market

• 18.1. France Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ketolides Market

• 19.1. Italy Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ketolides Market

• 20.1. Spain Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ketolides Market

• 21.1. Eastern Europe Ketolides Market Overview
• 21.2. Eastern Europe Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ketolides Market

• 22.1. Russia Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ketolides Market

• 23.1. North America Ketolides Market Overview
• 23.2. North America Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ketolides Market

• 24.1. USA Ketolides Market Overview
• 24.2. USA Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ketolides Market

• 25.1. Canada Ketolides Market Overview
• 25.2. Canada Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ketolides Market

• 26.1. South America Ketolides Market Overview
• 26.2. South America Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ketolides Market

• 27.1. Brazil Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ketolides Market

• 28.1. Middle East Ketolides Market Overview
• 28.2. Middle East Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ketolides Market

• 29.1. Africa Ketolides Market Overview
• 29.2. Africa Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ketolides Market Competitive Landscape And Company Profiles

• 30.1. Ketolides Market Competitive Landscape
• 30.2. Ketolides Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Ketolides Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca PLC
• 31.4. Abbott Laboratories
• 31.5. GSK PLC
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Eli Lilly and Company
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Astellas Pharma Inc.
• 31.10. Daiichi Sankyo Company Limited
• 31.11. Shionogi & Company Limited
• 31.12. Dr. Reddys Laboratories Ltd.
• 31.13. Taisho Pharmaceutical Co. Ltd.
• 31.14. Glenmark Pharmaceuticals Ltd.
• 31.15. Zhejiang Yongtai Technology Co. Ltd.

32. Global Ketolides Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ketolides Market

34. Recent Developments In The Ketolides Market

35. Ketolides Market High Potential Countries, Segments and Strategies

• 35.1 Ketolides Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Ketolides Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Ketolides Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer